Cargando…
Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer's Disease
Sporadic Alzheimer's disease (AD) is an emerging chronic illness characterized by a progressive pleiotropic pathophysiological mode of actions triggered during the senescence process and affecting the elderly worldwide. The complex molecular mechanisms of AD not only are supported by cholinergi...
Autores principales: | Leclerc, Benoît, Abulrob, Abedelnasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576798/ https://www.ncbi.nlm.nih.gov/pubmed/23476143 http://dx.doi.org/10.1155/2013/589308 |
Ejemplares similares
-
Comparison of T(2) and T(2)(*)-weighted MR molecular imaging of a mouse model of glioma
por: Blasiak, Barbara, et al.
Publicado: (2013) -
Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022) -
Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development
por: Nordberg, Agneta
Publicado: (2011) -
Molecular imaging biomarkers for cell-based immunotherapies
por: Haris, Mohammad, et al.
Publicado: (2017) -
In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes
por: Bertrand, Marie-Jeanne, et al.
Publicado: (2019)